Related Experiment Video
Updated: Aug 6, 2025

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
The relationship between obstructive sleep apnea and circulating tau levels: A meta-analysis.
Zhi-Wei Huang1, Hui-Xue Zeng2, Ya-Ping Huang2
1Department of Otolaryngology, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, Fujian Province, People's Republic of China.
Obstructive sleep apnea (OSA) is linked to higher levels of total tau (T-tau) and phosphorylated tau (P-tau) in the blood. This meta-analysis suggests a significant association between OSA and increased circulating tau biomarkers.
Area of Science:
- Neuroscience
- Sleep Medicine
- Biomarkers
Background:
- Alzheimer's disease (AD) is a progressive neurodegenerative disorder.
- Tau protein is implicated in AD pathogenesis.
- The relationship between obstructive sleep apnea (OSA) and circulating tau is not well understood.
Approach:
- A systematic meta-analysis was conducted using data from PubMed, Embase, and Web of Science.
- Circulating total tau (T-tau) and phosphorylated tau (P-tau) levels in OSA and control groups were quantitatively analyzed.
- Standardized mean difference (SMD) was calculated to assess the association.
Key Points:
- Seven studies with 306 OSA patients and 233 controls were included.
- Circulating T-tau levels were significantly higher in OSA patients compared to controls (SMD = 1.319).
- Circulating P-tau levels were also significantly elevated in OSA patients (SMD = 0.343).
Conclusions:
- Both T-tau and P-tau are significantly increased in individuals with OSA.
- These findings suggest a potential link between OSA and tau pathology.
- Further large-scale studies are needed to confirm these results.
More Related Videos
06:22A Pilot Study on the Repetitive Transcranial Magnetic Stimulation of Aβ and Tau Levels in Rhesus Monkey Cerebrospinal Fluid
Published on: September 3, 2021
07:08A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
Published on: October 20, 2016